Adaptimmune Therapeutics plc (ADAP)
NASDAQ: ADAP · Real-Time Price · USD
0.3000
0.00 (0.00%)
May 8, 2025, 4:00 PM - Market closed
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of $79.18 million as of May 8, 2025. Its market cap has decreased by -68.24% in one year.
Market Cap
79.18M
Enterprise Value
1.78M
1-Year Change
-68.24%
Ranking
Category
Stock Price
$0.30
Market Cap Chart
Since March 31, 2016, Adaptimmune Therapeutics's market cap has decreased from $575.60M to $79.18M, a decrease of -86.24%. That is a compound annual growth rate of -19.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2025 | 77.20M | -44.02% |
| Dec 31, 2024 | 137.90M | -23.43% |
| Dec 29, 2023 | 180.10M | -24.71% |
| Dec 30, 2022 | 239.20M | -59.17% |
| Dec 31, 2021 | 585.90M | -29.78% |
| Dec 31, 2020 | 834.40M | 561.17% |
| Dec 31, 2019 | 126.20M | -79.02% |
| Dec 31, 2018 | 601.40M | -3.93% |
| Dec 29, 2017 | 626.00M | 118.35% |
| Dec 30, 2016 | 286.70M | -50.19% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 697.29B |
| Johnson & Johnson | 378.48B |
| UnitedHealth Group | 355.95B |
| AbbVie | 332.73B |
| Novo Nordisk | 301.56B |
| Abbott Laboratories | 233.05B |
| Novartis AG | 218.96B |
| AstraZeneca | 217.30B |